Assuming the panel on 9/16 rejects them as I believe, what is ARNA fail value:  2.50.  ARNA has the best chance to get an FDA panel nod I believe that, but the likely scenerio is ARNA will also fail & so will OREX, joining VVUS, as failures.  On to ARNA:

ARNA drug is so safe, it has no efficency.

ARNA drug is so efficent, they got a whopping $50 million upfront from their partner. ARNA current market cap is 800 million. The valuation of ARNA is an absolute joke. It will take approval PLUS blockbuster sales to be fairly valued here at 7. Scary thing is, ARNA may not get approved by the panel like every ARNA YHOO board long believes because the drug works just like a placebo. Check out BLOSSOM & BLOOM results….How close does the late stage trials meet the 5% weight loss to placebo recommendation by FDA….let me tell you how close, IT DOESN’T.

So many pumpers out on this stock it makes me sick. ARNA is going to be shorted into the ground at these levels and when the ARNA longs get stiffed armed by the panel on 9/16 they will be left with 50 million bucks, a stock that will be cut in 2/3 with a butchers knife, a broken heart and broken dreams.

Welsh